SAN ANTONIO -- For higher-risk surgical patients, outcomes were not helped by more aggressive, individualized perioperative blood pressure (BP) management targets, two trials found. In the ...
Patients who undergo single-port robotic prostate or kidney surgery tend to have less blood loss and postoperative pain and shorter hospital stays compared with patients undergoing multi-port robotic ...
Across the IT industry, certification is on the rise. What was once a “resume boost” has become a requirement for navigating the complexity of hybrid infrastructure, multi-cloud operations, and modern ...
Aspen Surgical (“Aspen”), a portfolio company of Audax Private Equity ("Audax"), a leading manufacturer of surgical and medical devices, announced an expansion of its portfolio following the recent ...
Apple this week released a new version of its MagSafe Charger with Qi2 25W certification. It is available to order now with a one-meter or two-meter USB-C cable attached to it, with pricing ranging ...
Healthcare organizations are facing no shortage of challenges nowadays. Among some of the biggest, as shown by organizations including The American Hospital Association and Deloitte Center for Health ...
KUALA LUMPUR, Sept 10 (Reuters) - The European Union has recognised the Malaysian Sustainable Palm Oil (MSPO) certification as a credible standard that can facilitate compliance with EU's new ...
Perioperative nivolumab not only extends event-free survival (EFS) but also does not compromise quality of life in patients with resectable non-small cell lung cancer (NSCLC), including those with ...
Nearly 1 in 60 patients with cesarean delivery suffered severe perioperative surgical morbidity, more often with intrapartum delivery, a California billing code study of almost 600,000 cases reported.
Pembrolizumab significantly reduced the risk of event free survival events by 30% compared with standard of care. The Food and Drug Administration (FDA) has approved Keytruda ® (pembrolizumab) for the ...
Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): Primary analysis of Ph3 DeLLphi-304. An international, multicenter, prospective randomized trial ...
Please provide your email address to receive an email when new articles are posted on . Addition of perioperative durvalumab to standard chemotherapy improved outcomes for locally advanced gastric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results